Guides to the Saudi regulatory landscape.
Practical, source-cited walk-throughs of the Saudi regulatory and commercial terrain — registration pathways, market-entry programs and the rules that decide who wins. Built for BD, market-access and regulatory teams.
SFDA registration
Steps, documents, indicative fees and statutory timelines across all five SFDA pathways — drugs, medical devices, cosmetics, food/supplements and herbal.
Drug pricing & reimbursement
How SFDA sets your price (external reference pricing), the pricing pathway, lifecycle price erosion, the new economic-evaluation (HTA) mandate, and the NUPCO / CHI formulary route.
Government tenders & NUPCO
Who buys (NUPCO, MOH, the health clusters, military), the tender cycle end to end, the SFDA-registration prerequisite, the local-content price preference, and how to qualify and win.
Localization & Vision 2030
The local-content price preference, the Mandatory List, Lifera and tech-transfer routes, the localization spectrum, and the call on whether to manufacture in the Kingdom.
The Saudi RHQ program
The 30-year tax holiday, the government-contract rule, who qualifies, the setup process — and why 700+ multinationals (pharma among them) moved their regional HQ to Riyadh.
These guides are informational and not legal, regulatory or tax advice. Saudi rules, fees and programs change — always confirm against the official source (SFDA, MISA, the Royal Commission for Riyadh City) and a qualified advisor before acting. RaqibHealth cites its sources on every record. info@raqibhealth.com · RaqibHealth home